Stockreport

Mineralys Therapeutics Announces Q3 2024 Results and Updates [Yahoo! Finance]

Mineralys Therapeutics, Inc.  (MLYS) 
PDF Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on developing treatments for hypertension, chronic kidney disease, and related condi [Read more]